BERNAMA
SHAH ALAM, April 12 (Bernama) -- The cost of treating end-stage chronic kidney disease (CKD) in Malaysia has surged sharply from RM572 million in 2020 to RM3.3 billion annually at present, following a steady rise in cases each year.
Go to News Site